Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF in AML Induction
NCT00820976Phase 3Completed
- Sponsor
- Turkish Leukemia Study Group
- Start
- Mar 1996
- Primary completion
- Mar 2000
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of filgrastim in acute myeloid leukemia (AML), sponsored by Turkish Leukemia Study Group. Started Mar 1996; status: completed.
02
Drugs
filgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00820976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820976.